In light of our findings, we provide new evidence that GOLPH3 promotes CRC metastasis via facilitating STAT3 activation and regulating ZEB1 and integrin α3 expression, supporting the use of GOLPH3 as a potential therapeutic target for CRC in the future. This evidence concerns the gene STAT3 and colorectal carcinoma.